Related Experiment Videos
Gastrointestinal mesenchymal tumors - immunophenotypic classification and survival analysis.
Pierre Rudolph1, Anna Maria Chiaravalli, Ursula Pauser
1Department of Pathology, University of Kiel, Michaelisstr. 11, 24105 Kiel, Germany. prudolph@path.uni-kiel.de
Virchows Archiv : an International Journal of Pathology
|September 21, 2002
Summary
This study reclassifies gastrointestinal mesenchymal tumors beyond CD117-positive GISTs, revealing distinct subtypes with varied behaviors and survival outcomes. Improved classification aids in understanding tumor heterogeneity and predicting malignancy potential.
Area of Science:
- Gastrointestinal Pathology
- Oncology
- Immunohistochemistry
Background:
- Current classification of gastrointestinal tumors (GIST) as CD117-positive mesenchymal neoplasms is insufficient, excluding similar histological cases.
- Need for improved classification to encompass the full spectrum of gastrointestinal mesenchymal tumors and their biological behavior.
Purpose of the Study:
- To re-evaluate and refine the classification of gastrointestinal mesenchymal tumors using immunohistochemical analysis.
- To identify distinct subgroups based on immunophenotype and assess their clinical behavior and prognostic implications.
Main Methods:
- Immunohistochemical analysis of 244 mesenchymal tumors with GIST-like histology.
- Classification into GISTs (CD117+), GINSTs (CD117-, CD34+), GILTs (actin/desmin+), GIGTs (S-100/GFAP+), GINTs (S-100/GFAP+/neuronal/glial+), and GIFTs (vimentin+).
- Evaluation of tumor location, mitotic activity, size, nuclear pleomorphism, and patient follow-up for malignancy and survival.
Main Results:
- Identified six distinct immunophenotypic subgroups: GIST, GINST, GILT, GIGT, GINT, and GIFT, with GIST being most common.
- GINSTs and GILTs showed preferential locations in the stomach/duodenum and large intestine, respectively.
- Malignant behavior was observed in all subtypes except GINTs; distal location, high mitotic activity, large size, and pleomorphism correlated with malignancy.
Conclusions:
- Gastrointestinal mesenchymal tumors are immunophenotypically and biologically heterogeneous, necessitating a classification beyond the current GIST definition.
- The newly defined subgroups exhibit distinct clinical behaviors and survival outcomes, highlighting the importance of accurate subtyping for prognosis.
- Immunohistochemistry is crucial for differentiating these tumors and predicting their malignant potential.